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Abstract
Despite the ability of combination antiretroviral treatment (cART) to reduce viral burden to nearly undetectable levels in
cerebrospinal fluid and serum, HIV-1 associated neurocognitive disorders (HAND) continue to persist in as many as half the
patients living with this disease. There is growing consensus that the actual substrate for HAND is destruction of normal
synaptic architecture but the sequence of cellular events that leads to this outcome has never been resolved. To address
whether central vs. peripheral myeloid lineage cells contribute to synaptic damage during acute neuroinflammation we
injected a single dose of the HIV-1 transactivator of transcription protein (Tat) or control vehicle into hippocampus of wild-
type or chimeric C57Bl/6 mice genetically marked to distinguish infiltrating and resident immune cells. Between 8–24 hr
after injection of Tat, invading CD11b
+ and/or myeloperoxidase-positive leukocytes with granulocyte characteristics were
found to engulf both microglia and synaptic structures, and microglia reciprocally engulfed invading leukocytes. By 24 hr,
microglial processes were also seen ensheathing dendrites, followed by inclusion of synaptic elements in microglia 7 d after
Tat injection, with a durable microgliosis lasting at least 28 d. Thus, central nervous system (CNS) exposure to Tat induces
early activation of peripheral myeloid lineage cells with phagocytosis of synaptic elements and reciprocal microglial
engulfment of peripheral leukocytes, and enduring microgliosis. Our data suggest that a single exposure to a foreign
antigen such as HIV-1 Tat can lead to long-lasting disruption of normal neuroimmune homeostasis with deleterious
consequences for synaptic architecture, and further suggest a possible mechanism for enduring neuroinflammation in the
absence of productive viral replication in the CNS.
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Introduction
Despite the ability of cART to efficaciously suppress replication
of HIV-1, at least one-half of virus-infected persons develop HIV-1
associated neurocognitive disorders (HAND) [1,2]. This raises the
question of how neurologic disease remains manifest, albeit in a
milder, more indolent form despite effective control of HIV-1
replication with cART. Furthermore, how can HIV-1 affect
normal synaptic communication between neurons in different
brain regions [3], considering vanishingly low copy numbers of the
virus in patients treated with cART? Because neuropathologic
findings associated with HIV-1 infection of the CNS are usually
obtained from postmortem tissue and cannot provide information
about antecedent interactions between HIV-1, populations of
immune effector cells and neurons, we performed in vivo modeling
experiments to help answer these questions.
Microglial activation, multinucleated giant cells, and gliosis due
to astrocytic hypertrophy are considered nonspecific hallmarks of
HIV-1 infection and inflammation in the CNS [4]. In contrast, the
severity of premortem neurologic disease has been correlated with
loss of synaptic complexity, as well as macrophage burden in the
CNS [5–8]. An early investigation of these neuropathologic events
by Jones et al. [9] demonstrated infiltration of neutrophils one day
after intracerebroventricular administration of either single or
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lymphocytes 6 d later. They noted astrocytosis, apoptotic cells,
ventriculomegaly and a decrease in hippocampal glutamate:-
GABA ratios, leading to the conclusion that inflammatory cell
infiltration, glial activation and neurotoxicity could be triggered by
the presence of Tat in the CNS. Similarly, we have shown that
acute exposure to Tat can induce dramatic and durable
morphologic changes in rough endoplasmic reticulum (RER)
and mitochondria, both in vitro and in vivo [9]. These changes are
similar to what is observed in postmortem brain tissue of patients
with HAND [10] - prompting us to investigate the sequence of
neuroimmune events that occurred after stereotactic injection of
Tat in vivo. One of the key questions we hoped to address through
these experiments was the relative contribution of infiltrating
myeloid cells versus brain-resident microglia to destruction of
normal synaptic architecture [11–14].
For this study, we have elected to use HIV-1 Tat in a simplified
experimental model of HAND for the following reasons: (1)
patients with undetectable viral loads (and hence a vanishingly
small amount of gp120 present in budding virions from
productively infected cells in the CNS) still have HAND [15]; (2)
ample data exists to validate the presence of Tat in both lymph
and CNS compartments with an equal ability to induce
transactivation [16]; (3) more ‘‘pathophysiologically’’ faithful
murine models of HAND such as the CD34-NSG HIV-1 infected
mice described in our recent publication by Dash et al. [17] still
require technically difficult experimental maneuvers to create
animals in sufficient quantity for in vivo experiments described in
this paper; and (4) perhaps most importantly, we needed to
temporally and spatially control the nature of a single exposure to
Tat in the CNS in order to investigate the effects of persistent
immune activation on normal synaptic architecture.
Using mice transgenic for fluorescently labeled peripheral and
central mononuclear phagocytes, we now report that exogenous
application of a single dose of Tat into the CNS induced acute
infiltration of peripheral mononuclear phagocytes and myeloper-
oxidase-positive granulocytes, starting as early as 8 hours after the
injection. We further show, for the first time, infiltrating
inflammatory leukocytes engulfed dendritic spines and microglial
processes. In contrast, microglia near the site of Tat exposure
remained in a hypertrophied, arborized phenotype for at least 28
days, but were nevertheless found to acutely engulf mononuclear
phagocytes as well as synaptic structures including axon terminals,
dendrites, and dendritic spines. Taken together our data suggest a
single exposure to the HIV-1 regulatory Tat protein can
transiently increase infiltration of inflammatory peripheral leuko-
cytes, resulting in microgliosis accompanied by disruption of
normal synaptic architecture.
Results
Preclinical in vivo models for HAND include: the administration
of HIV-1 neurotoxic gene products, gp120 and Tat into the CNS;
introduction of HIV-1 infected mononuclear cells into the CNS;
transgenic mouse and rat models (e.g., GFAP-gp120 and GFAP-
Tat), and in vivo simian immunodeficiency virus (SIV) infection of
the CNS, SIVE [9,18–24]. These have collectively recapitulated at
least some neuropathologic findings found in patients with HAND
[4] - including microglial activation, infiltration of perivascular
macrophages and astrocytosis. However, the persistence of HAND
in the face of low or absent viral loads has forced us to
reinvestigate why the presence of secretory neurotoxins in the
neuropil or synapse alone cannot fully explain the neuropatho-
genesis of HAND.
Time course of neuroinflammation following stereotactic
injection of Tat
We elected to investigate the effects of acute hippocampal
exposure to HIV-1 Tat because a large body of literature using
both rats and mice has demonstrated robust Tat-associated
changes in synaptic architecture in this brain region as well as
behavioral consequences [25–29]. Initial experiments with higher
in vivo doses (25 mg/5 ml) of Tat used in a previously published
report [30], resulted in significant neuronal loss and cavitation at
the injection site. This prompted us to reduce the dose of Tat by
40% (i.e. 15 mg/5 ml) in order to investigate potential effects of Tat
on synaptic architecture as well as changes in populations of
immune effector cells. Thus, we injected Tat or vehicle control
into the hippocampus of wild-type mice and performed a time
course experiment, sacrificing mice 8 hrs, 1 d, 7 d and 28 d after
injection. To survey leukocyte responses to Tat, we performed
immunocytochemical studies to assess the relative expression of
leukocyte integrin CD11b around the injection site. Even though
CD11b does not differentiate between leukocyte subtypes [31], we
were able to distinguish between infiltrating leukocytes with a
round morphology and brain-resident microglia with a ramified
morphology,
Examination of hippocampal tissue around the site of Tat
injection revealed that both Tat and saline caused microglial
activation and fragmentation adjacent to the needle track at
8 hours following injection, with few infiltrating leukocytes
(Figure 1, Panels A and E). However, 1 d after the hippocampal
inoculation, we detected a striking number of infiltrating
leukocytes entirely encasing the center of the injection site,
reminiscent of a granulomatous response, in mice that received
Tat (Fig. 1B), but not in animals that received vehicle (Fig. 1F).
Indeed, 1 d after vehicle treatment only a few leukocytes infiltrated
the injection site with some microglia that remained in a
surveillance phenotype (i.e. ramified morphology). At a later time
point (7 days after injection), both treatments induced microgliosis.
However, Tat treatment induced a much larger territory of
microgliosis that extended into adjacent fields (data not shown), in
contrast to control vehicle treatment. Finally, at an extended time
point (28 days following injection), Tat treatment resulted in
persistent microgliosis whereas control vehicle treatment demon-
strated scattered cells with increased CD11b expression, possibly
labeling dendritic cells, but no evidence of reactive microglial
morphology. To further investigate this finding, we performed
additional studies with both antibodies to CD11b and ionized
calcium binding adapter molecule-1 (Iba-1) [32]. 28 d after
exposure to Tat we observed reactive microglial morphology both
by CD11b expression (Figure S1, Panel D) and Iba-1 expression
(Panel B), while exposure to vehicle control 28 d later revealed
fairly normal ramified morphology of microglia by CD11b, with a
single very bright CD11b cell that may reflect a dendritic cell
(Panel C) and Iba-1 (Panel A), respectively.
Creation of chimeric models to investigate the role of
peripheral vs. central immune responses to stereotactic
injection of Tat
Because maximal infiltration of peripheral leukocytes occurred
24 hrs after Tat injection, we chose this time point to investigate
whether there is a differential contribution of central and
peripheral immune effector cells to the neurotoxic effects of Tat
in the hippocampus. To do this, we generated bone marrow
chimeras between CD45.1 mice and mice that express green
fluorescent protein (GFP) under the control of the CX3CR1
promoter. In these mice, circulating monocytes, subsets of NK and
HIV Tat and Sustained Neuroinflammation
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examined the ability of Tat to induce leukocyte infiltration in
comparison to control vehicle. We used three experimental
groups: (1) bone marrow from CX3CR1
+/2 heterozygotes
engrafted into a congenic CD45.1 host, (2) bone marrow from
CX3CR1
+/+ homozygotes engrafted into a CD45.1 host and (3)
CD45.1 marrow engrafted into a heterozygous CX3CR1
+/2 host.
We reasoned that CD45.1 hosts engrafted with CX3CR1-
GFP
+/2 marrow would allow us to assess the contribution of GFP
+
peripheral myeloid subsets of leukocytes to neuroinflammation,
which would appear as non-process-bearing amoeboid GFP+ cells
in the vicinity of the injection site for Tat. Conversely,
heterozygous CX3CR1-GFP
+/2 hosts engrafted with marrow
from CD45.1 animals were used to examine the contribution of
GFP
+ microglia, which might appear as rod-like, reactive
microglia or microglia with processes convergent on the injection
site for Tat. Finally, CD45.1 hosts engrafted with marrow from
either CX3CR1-GFP
+/2 heterozygous or CX3CR1-GFP
+/+
homozygous mice were used to further determine whether
CX3CR1 played an integral role in recruiting peripheral
leukocytes to augment Tat-induced neuroinflammation. Pilot
experiments revealed that engraftment successfully repopulated
precursor pools for mononuclear phagocytes after 4 weeks. Thus 4
weeks after engraftment, mice received Tat or control vehicle into
the right hippocampus as described in the Materials and Methods
section.
We speculated that if microglia contribute to the inflammatory
changes and neuronal destruction that occur after injection of Tat
into the CNS, they would not remain in a resting ramified
morphologic phenotype in the CX3CR1 host, but would likely
assume a reactive phenotype, with a rod-like appearance, devoid
of branching processes. Conversely, if peripheral leukocytes
infiltrate the CNS to contribute to the initial inflammatory
changes after injection of Tat, we expected to observe a large
influx of green cells in the CD45.1 congenic host. However,
leukocytes with a low expression level of GFP that infiltrate the
parenchyma are likely to represent CX3CR1
low ‘‘inflammatory’’
monocytes, which are selectively recruited to areas of inflamma-
tion [35]. Figure 2, Panel A demonstrates that 24 hours after
injection of Tat, GFP-positive cells were nearly undetectable in the
hippocampus of CD45.1 host mice engrafted with heterozygous
CX3CR1-GFP
+/2 marrow. Panel B depicts the injection site,
magnified 2.56, to demonstrate that GFP
+ cells are present but
difficult to visualize without either longer exposure times or
augmentation of their signal with anti-GFP antibody (used in
panels C–F). These results demonstrate that infiltrating macro-
phages after Tat injection have low levels of CX3CR1 expression
suggesting that they are derived from resting, circulating
monocytes [36]. This also indicated the need to use an anti-GFP
antibody to amplify the GFP signal in order to fully appreciate
CNS infiltration by peripheral mononuclear cells. Thus, we used
anti-GFP amplification for all further studies of irradiation
chimeras that were transgenic for CX3CR1-GFP. Use of the
anti-GFP antibody in an adjacent tissue section revealed a
dramatic infiltrate of cells with low levels of GFP expression
24 hrs after Tat injection (Panel C), while the vehicle control
resulted in infiltration of GFP
+ cells in the region of the needle
track but not in the parenchyma, suggesting that mechanical
breach of the blood brain barrier alone did not account for
recruitment of GFP-expressing cells in the parenchyma (Panel D).
Because of concerns that total body irradiation during the
generation of CD45.1 mice engrafted with CX3CR1-GFP
+/2
marrow would lead to damage to the blood-brain barrier (BBB),
we repeated our experiments with head-shielding to prevent
radiation injury to the brain [37–39]. Quantification of our results
using one-way ANOVA with Tukey’s HSD post-hoc test
demonstrated that head shielding made no difference to monocyte
infiltration into the hippocampus after Tat or control vehicle
injection. There were 11706177 GFP+ cells with shielding (N=3)
vs. 12716108 GFP+ cells without shielding (N=3)(p=0.815)
infiltrating into the hippocampus 24 hr after Tat injection and
18612 GFP+ cells with shielding (N=3) vs. 22+4 GFP+ cells
without shielding (N=3)(p=1.00) after control vehicle injection
(Figure S2, Panel A). However, there was a significant difference in
the monocyte infiltration between Tat and control vehicle
treatments (p,0.001, regardless of head shielding).
Figure 1. HIV-1 Tat causes enduring microglial activation and transient leukocyte infiltration into hippocampal neuropil. Both
microglia and leukocytes were visualized with CD11b
+ and they could be distinguished by their morphology because infiltrating leukocytes had
round or ovoid morphology whereas microglia had ramified, often hypertrophied processes. Wild-type mice received either Tat (top panels, n=3) or
saline control vehicle (bottom panels, n=3) injection into the right hippocampus and were sacrificed 8 hours (Panels A and E), 1 (Panels B and F), 7
(Panels C and G) and 28 (Panels D and H) days later, and hippocampal tissue sections processed for CD11b immunocytochemistry as described in
Methods. All microscopic fields depicted here are directly adjacent to the injection site. White arrows point to examples of ramified microglia and
white arrowheads point to examples of round or ovoid infiltrating leukocytes. The blue arrowhead in E points to a microglial cell fragment that was
frequently seen in both the Tat and saline treatment groups 8 hours after injection. These cellular fragments typically appeared as isolated globules
scattered in and around the injection site but were much smaller than leukocytes. Scale bar=16 mm for all micrographs.
doi:10.1371/journal.pone.0023915.g001
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in response to Tat
To further investigate the role of CX3CR1 in the ingress of
peripheralmononuclearcells,weinjected Tat into the hippocampus
of CD45.1 mice engrafted with homozygous CX3CR1-GFP
+/+
marrow. Mice engrafted with homozygous CX3CR1-GFP
+/+
marrow that received Tat (Figure 2, Panel E) had significantly
greaternumbersofGFP+ cellsinthe parenchyma(2089696,N=2)
than CD45.1 mice engrafted with heterozygous CX3CR1/GFP
+/2
marrow that also received Tat (12716108, N=3) (p,0.001, one-
way ANOVA with Tukey’s HSD post-hoc test) (Panel C)(Figure S2,
Panel B). Interestingly, the numbers of adoptively transferred
immune cells from homozygous CX3CR1/GFP
+/+ mice that
infiltrated into the CNS were also much higher in the vehicle
control (1457688, N=2 vs. 2264, N=3)(p,0.001, one-way
ANOVA with Tukey’s HSD post-hoc test)(Panel F vs. Panel
D)(Figure S1, Panel B).
Next we investigated the morphology of brain-resident
microglia 24 hrs after injection of Tat or control vehicle into the
hippocampus of CX3CR1-GFP
+/2 that had been engrafted with
bone marrow from CD45.1 mice. As in Figure 2, we noted
dramatic infiltration of CD11b
+ leukocytes around the needle
track and parenchyma in response to Tat (Figure 3, Panel A),
while Panel B shows CD11b
+ leukocyte infiltration primarily
around the needle track with scattered infiltration in the
parenchyma in response to control vehicle. Figure 3, Panels C
and D show that microglia adjacent to the injection site and
further away from the needle track in hippocampus remained in
ramified morphology (Figure 3, Panel F); this is even more clearly
apparent in higher magnification images (Figure 4). There was
marked infiltration of CD11b
+/GFP
2 cells adjacent to the needle
track and in hippocampus of Tat-treated (Figure 3, Panel E)
relative to mice treated with vehicle alone (Figure 3, Panel F),
further suggesting that infiltrating leukocytes are primarily
Figure 2. Stereotactic injection of Tat induces a differential effect on infiltrating inflammatory leukocytes depending on gene dose
of CX3CR1. Montage of microscopic fields 24 hours after Tat (Panels A–C, E) or control vehicle (Panels D, F) injection into the right hippocampus of
irradiation chimeras. Images in Panels A, B, C, and D were taken from CD45.1 host mice engrafted with heterozygous CX3CR1/GFP
+/2 bone marrow,
whereas images E and F were from CD45.1 host mice engrafted with homozygous CX3CR1/GFP
+/+ bone marrow. A, C, D, E, and F were taken with a
46objective with the same 0.9 sec exposure time and B was taken with a 106objective with a longer exposure time (4 sec) to intensify the weak
fluorescence of the GFP signal. Panel A and B depict very low expression of fluorescence from infiltrating GFP expressing leukocytes, while Panels C–F
depict amplified GFP expression with anti-GFP antibody and Alexa 488 conjugated second antibody treatment. All experimental and control groups,
n=3 independent replicates. Scale bar=100 mm for Panels A, C, D, E, and F; 40 mm for B.
doi:10.1371/journal.pone.0023915.g002
HIV Tat and Sustained Neuroinflammation
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Analysis of tissue sections up to 500 mm from the injection site
confirmed that Tat induced a differential increase in leukocyte
infiltration compared to saline control vehicle (data not shown).
To further investigate the response of brain-resident microglia
to Tat-induced neuroinflammation, we examined three-dimen-
sional (3D) reconstructions of brain tissue 24 hrs after Tat injection
into the hippocampus of CX3CR1-GFP
+/2 hosts engrafted with
CD45.1 bone marrow. We differentiated between microglia based
on their ramified morphology, relatively uniform GFP expression
and lower levels of CD11b expression when compared to
infiltrating leukocytes, which were amoeboid, lacking GFP
expression, frequently convergent and had higher levels of
CD11b expression. Figure 5 demonstrates two examples of
infiltrating leukocytes that appear to phagocytose microglia (blue
arrows, Panel A) and one example of a microglial cell that appears
to phagocytose leukocytes (white arrow, Panel A). Panels B and C
show CD11b and GFP expression in these cells, respectively.
Panels D and E show the corresponding cross-sectional (XYZ)
view (see Methods: Image Analyses) to help validate leukocyte
phagocytosis of microglia and conversely Panel F shows the same
3D view of microglial phagocytosis of leukocytes. When
phagocytosis occurred in hippocampal parenchyma, CD11b
+
leukocyte fragments were clearly visible inside GFP
+ microglia or
vice-versa.
Role of granulocyte infiltration in response to
stereotactic injection of Tat
Jones [9] reported that neutrophil infiltration occurred 24 hrs
after intraventricular administration of Tat, and we also noted the
presence of round cells adjacent to the injection site that were
CD11b
+. We performed additional immunocytochemical studies
with a myeloperoxidase marker (MPO) to identify granulocytes
[40], using CNS tissue from congenic CD45.1 mice engrafted with
homozygous CX3CR1-GFP
+/+ donor marrow because we
reasoned that this genotype would increase the number of
infiltrating inflammatory leukocytes, collected 24 hrs after injec-
tion with Tat. Figure 6 shows a single representative field of right
hippocampus adjacent to the injection site with four-color labeling
of antigens and GFP that identify mono- and polymorphonuclear
Figure 3. Stereotactic injection of Tat into hippocampus does not induce amoeboid microglial morphology in irradiation chimera.
Montage of micrographs 24 hours after Tat (Panels A, C, and E) or control vehicle (Panels B, D, and F) injection into right hippocampus in CX3CR1/
GFP
+/2 hosts engrafted with congenic CD45.1 bone marrow. A and B show CD11b
+ cells (red), C and D show GFP
+ microglia (green) present in the
same section, and E and F presents an overlay of the two images - highlighting the CD11b
+/GFP
+ co-expressing cells (orange) as well as the single
positive cells. The inset in panel E shows a ramified GFP+ microglial cell (white arrowhead) in higher magnification and the 2 infiltrating CD11b+
peripheral leukocytes (red). All experimental and control groups, n=3 independent replicates. Scale bar shown in Panel A=100 mm for all figures.
doi:10.1371/journal.pone.0023915.g003
HIV Tat and Sustained Neuroinflammation
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demonstrates that a substantial proportion of infiltrating leuko-
cytes were CD11b
+/CX3CR1-GFP
2 cells that expressed MPO
(blue; blue arrowheads). There was a similar degree of co-
localization between GFP+ and CD11b+ infiltrating leukocytes
(white arrowheads). In contrast, white arrows in Panel A identify
CD11b
+low/MPO
2/GFP
2 ramified microglia.
To validate our interpretation that a substantial population of
round cells infiltrating the CNS 24 hours after the hippocampal
injection of Tat were indeed granulocytes, a blinded neuropathol-
ogist (M.J.) examined H&E stained slides of hippocampus and
confirmed the presence of polymorphonuclear leukocytes in mice
that received Tat. This was consistent with our data that
demonstrated cells with neutrophil morphology only in tissue
sections from mice that had received Tat (Fig. 6B, bluearrowheads),
but not in vehicle-treated controls (data not shown). In chimeric
mice that received head shielding during irradiation, the majority
(64%) of the total number of leukocytes (GFP+ and MPO+ cells)
that infiltrated the hippocampus in response to Tat appeared to be
granulocytes (21106379 MPO+ cells 24 hr after Tat injection vs.
32610 MPO+ cells 24 hr after vehicle control)(Figure S2, Panel C).
Microglial-neuronal contact in response to stereotactic
injection of Tat
Additionally, we examined the intricate spatial relationships
between CD11b
+ ramified microglia and neuronal dendrites. To
do this, we took advantage of thy1-YFP transgenic mice, in which the
YFP reporter gene is expressed in hippocampal and cortical neurons.
We injected Tat or saline into the right hippocampus of these
animals, and 24 hrs later examined the site of injection using
immunocytochemical staining methods. Even though microglia
retained a ramified morphology after stereotactic injections, they
developed markedly hypertrophied processes in response to Tat
treatment (Figure 7 Panels B and D ipsilateral, and F and H
contralateraltotheinjection)comparedtovehicletreatment(Figure7
A and C ipsilateral, and E and G contralateral to the injection).
In Figure 8, 3D views of saline-exposed hippocampus (collected
at 24 hrs following intracranial injection) are depicted in Panels
A–C and cross-sectional confocal-like XYZ views are depicted in
the corresponding Panels D–F. The extensive and intricate
neuritic processes emanating from neuronal soma can be readily
appreciated, as can the fact that there are almost no CD11b
+
infiltrating leukocytes adjacent to neuritic processes, and that
CD11b
+ ramified processes of microglia surround or even
ensheath YFP-expressing hippocampal neurons. Points where
cell-to-cell contact between microglia and neurons occur are
illustrated in 3D and their corresponding XYZ view with blue
arrowheads. In striking contrast, Figure 9 demonstrates similar
views of the hippocampus from Tat-exposed animals, also
collected at 24 hrs following intracranial injection. The images
reveal infiltrating CD11b
+ round leukocytes, one of which is
phagocytosing a YFP
+ dendritic spine (green arrowhead, Panel A),
while CD11b
+low microglia are ensheathing neuronal processes
(blue arrowheads, Panel A), 24 hrs after injection of Tat into
hippocampus. From these data, we concluded that infiltrating
leukocytes with an inflammatory phenotype not only attack brain-
resident microglia but phagocytose synaptic elements in response
to Tat-induced neuroinflammation.
We next quantified the amount of contact between CD11b
+
structures, leukocytes and microglia, and YFP
+ neuronal struc-
tures. This was measured as the intersecting volume between the
two from 3D image sets at least 500 mm away from the stereotactic
injection site from 4 Tat treated (24 hr) and 3 vehicle treated
(24 hr) mice using Volocity 3DM software. Because of the
variability of hippocampal YFP expression between mice, we
normalized the intersecting volume between CD11b
+ and YFP
+
Figure 4. High resolution micrographs confirm lack of amoeboid microglial morphology following exposure to Tat in irradiation
chimera. Montage of high resolution micrographs illustrating the microglia remain in a ramified morphology 24 hours after Tat (Panels B, D) or
control vehicle (Panels A, C) injection into right hippocampus in CX3CR1/GFP
+/2 hosts engrafted with congenic CD45.1 bone marrow. Shown are
CD11b
+ cells (red) and GFP
+ microglia (green). While thickened processes are frequently observed, there is no evidence of amoeboid microglial
morphology. Panels A and B were taken from an area of the hippocampus near the injection site of vehicle and Tat, respectively, and C and D were
from the corresponding area of the hippocampus contralateral to the injection site of vehicle and Tat, respectively. All experimental and control
groups, n=3 independent replicates. Scale bar=20 mm.
doi:10.1371/journal.pone.0023915.g004
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PLoS ONE | www.plosone.org 6 September 2011 | Volume 6 | Issue 9 | e23915structures by dividing it with the total YFP
+ volume from each
individual image set. Morphometric quantification of these
volumes demonstrated a 41% increase in contact between
CD11b
+ leukocytes and microglia with neuronal structures after
Tat compared to vehicle treatment (2.41610
2665.3610
27 vs.
1.71610
2664.94610
27,P ,0.01 by T-test)(Figure S2, Panel D).
Immunoelectron microscopy of neuronal-microglial and
neutrophil interactions in response to stereotactic
injection of Tat
Because our light microscopic data could not fully resolve
whether apposition of microglia around neuritic processes resulted
in engulfment of synaptic elements in response to Tat, we
Figure 5. Stereotactic injection of Tat results in reciprocal engulfment of microglia and infiltrating leukocytes. Montage of higher
magnification micrographs with 3D reconstruction of GFP
+ microglia (green) interacting with infiltrating CD11b
+ leukocytes (red) in the right
hippocampus of mice injected with Tat 24 hours earlier (Panels A, B, and C) and XYZ views at different depths of the same image stack (Panels D, E,
and F). Blue arrowheads points to the corresponding locations where infiltrating leukocytes engulf microglia processes. Panel A shows a combined
view of CD11b (red) and GFP (green) expression, while panel B shows CD11b expression alone and panel C shows GFP expression alone. The white
arrowhead points to the location where GFP
+ microglial processes phagocytose a CD11b
+ infiltrating leukocyte. To further illustrate the phagocytic
nature of these cell-to-cell interactions, Panels D and E show the corresponding XYZ view of the location (the crossing point of the two blue cursor
lines) of the top and bottom blue arrowhead in panel A, respectively. Panel F shows the XYZ view of the location (the crossing point of the two white
cursor lines) of the white arrowhead in Panel A. Each side of individual grids=14 mm for Panels A–C, and the scale bar shown in Panel D=16 mm for
D–F. n=3 independent replicates for Tat treatment.
doi:10.1371/journal.pone.0023915.g005
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adaptor molecule 1 (Iba1) immunostained tissue sections collected
from the cortex of CX3CR1-GFP
+/2 mice 24 hr or 7d after
stereotactic injection of Tat (Figure 10). We reasoned that high
numbers of inflammatory granulocytes infiltrate brain parenchy-
ma 24 hrs after exposure to a single dose of Tat, but would be
largely absent 6 d later. These two time points would allow us to
distinguish whether there were any qualitative differences in
ultrastructural relationships between microglia or neutrophils and
neurons. For these studies, we used cortex, where similar
inflammatory changes in populations of infiltrating leukocytes
and microglia were observed (data not shown), and Iba-1 staining
was used to identify microglia. 24 hrs after Tat injection, we
observed an obvious increase in the prevalence of degenerating
neurons (versus saline controls) with the caveat that polymorpho-
nuclear granulocytes were frequently observed at the 24 hrs time
point, but not observed at 7 d. Some of the neuronal processes
were found surrounded by Iba1 immunopositive microglial
processes, which in turn were engulfed by granulocytes with a
typical multinucleated appearance (Inset box, Panel A, higher
magnification, Panel B) [41]. We also observed an increase in the
prevalence of cellular inclusions inside microglia (versus saline
controls), sometimes resembling synaptic elements (dendritic
spines and dendrites, axon terminals)(Panels C, D). 7 d after Tat
injection, we frequently observed cellular inclusions resembling
synaptic elements within microglia, but were unable to see any
polymorphonuclear granulocytes with or without inclusions
resembling synaptic elements or microglial processes in our
ultrastructural survey.
Discussion
In this study, we stereotactically injected a single dose of HIV-1
Tat into murine hippocampus and cortex to study the temporal
sequence of events that leads to the neuroinflammation and
abnormal synaptic architecture associated with HAND. Introduc-
tion of Tat into the CNS resulted in acute infiltration of leukocytes,
adjacent and remote to the injection site, with engagement of
microglia in cell-to-cell contact between synapses and invading
leukocytes with inflammatory phenotypes. A pragmatic caveat to
note is that we used an in vivo dose of Tat (3 mg/ml) that is $10006
the dose commonly used in in vitro experiments (1–100 nM). There
is no reliable way to measure the actual concentration of Tat in the
extracellular space in the CNS because no successful ELISA
strategy exists and because native Tat is incredibly sensitive to
oxidation. Thus, there are no published reports of local Tat
concentrations in the brains of patients with HAND, but ample
evidence of Tat transcripts in HAND brains [16,42]. When cell
lines are transfected with Tat, supernatants have extraordinary
neurotoxicity, with a theoretical LD50 in the femtomolar range, far
too small to be detected on a gel (Avi Nath, personal
communication). When Tat is produced for experimental use, it
is made and stored under reducing conditions, which are thought
to represent the extracellular environment in the CNS. However,
Tat is also extraordinarily sticky, and between its marked
sensitivity to oxidation and ability to bind even to silanized glass
surfaces (as in the syringe barrel and needle used in stereotactic
injections), we used Tat1–72 at a pharmacologic concentration (i.e.
3 mg/ml in our study) to abrogate these confounds.
While the majority of the population of microglia that we
surveyed in hippocampus exposed to Tat remained in a
surveillance phenotype without evidence of transformation into a
rod-like, reactive morphology (Figure 3, 4 insets), there was
widespread evidence of reciprocal engulfment (Figure 5) of
microglia and peripheral myeloid cells, raising the question of
whether microglia may attack invading inflammatory leukocytes.
Introduction of Tat into the CNS was also associated with
disruption of normal synaptic architecture, as reported previously
[28]. Our data cannot unequivocally differentiate the relative
contribution of microglia vs. peripheral myeloid cells to phagocytic
engulfment of normal synaptic architecture. However, qualita-
tively, our data in aggregate suggest that microglia do not simply
mimic the initial neurotoxic response of infiltrating leukocytes
24 hr after exposure to Tat. While infiltrating inflammatory
leukocytes robustly destroy microglia and neuronal dendritic
spines in their vicinity (Figure 4B, 9A, green arrowhead), microglia
remain largely ramified, albeit with hypertrophied processes
(Figure 4, Panels B, D), and appear to ensheath neurons
(Figure 7B, 9A, blue arrowheads).
The sequence of signaling events after Tat injection in our
model is complex and can be assumed to include release of the
Figure 6. Stereotactic injection of Tat into hippocampus
induces Infiltration of polymorphonuclear cells 24 hours later.
Panel A illustrates combined immunofluorescence staining of CD11b
(red), MPO (Blue), Iba-1 (white), and GFP (green) cells in a representative
tissue section from a congenic CD45.1 host engrafted with homozygous
CX3CR1/GFP
+/+ marrow that received Tat. Blue arrowheads point to
CD11b
+/MPO
+/GFP
2 infiltrating leukocytes, white arrowheads point to
CD11b
+/MPO
2/GFP
+ infiltrating leukocytes, and white arrows point to
CD11b
+low/MPO
2/GFP
2 ramified microglia. Panel B illustrates a 1006
oil-immersion image from H&E staining of an adjacent section from
Panel A and blue arrowheads point to polymorphonuclear cells. Scale
bar=16 and 8 mm for Panels A and B, respectively. n=3 independent
replicates for Tat treatment.
doi:10.1371/journal.pone.0023915.g006
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CCL2) well as up-regulation of VCAM-1 and ICAM-1, with the
ultimate biologic effect of transmigration of mononuclear cells
across the BBB into the CNS [43–48]. Inflammatory leukocyte
infiltration is likely to be further amplified by the ability of Tat to
increase the production of platelet-activating factor, PAF, a
chemotactic factor for granulocytes [49–53]. We do not yet know
whether the microglial response to Tat-induced chemotaxis of
peripheral inflammatory leukocytes in vivo is an attempt at host
defense of normal synaptic architecture, but it is interesting to
speculate that microglia may attack invading leukocytes, which
enter the CNS in response to local neuroinflammation and
chemokine release [48,54,55]. Microglia are also well recognized
for their contribution to the normal ‘‘pruning’’ and maintenance
Figure 7. Exposure to Tat alters microglial morphology and spatial relationships with neurons. Montage of thy-1 YFP
+ neurons (yellow)
and CD11b
+ (red) 24 hr after Tat (Panels B, D, F, H) or control vehicle (Panels A, C, E, G) injection into right hippocampus. Images in Panels A–D are
from the CA1–CA2 region about 1 mm away from the vehicle (A, C) or Tat (B, D) ipsilateral to the injection site. Images in Panels E–H are taken from
the CA1 region of the contralateral hippocampus of mice injected with vehicle (E, F) or Tat (G, H). Scale bar=20 microns. Note that CD11b+ microglia
(red) in control vehicle treated hippocampi exhibited a normal resting ramified morphology with comparatively thin processes that bear many small
appendages (A, C, E, and G), whereas CD11b+ microglia in Tat-treated hippocampi have an activated morphology with much thicker processes and
enlarged cell bodies. Some of the hypertrophied processes wrap around YFP
+ dendrites and cell bodies. Note that the number of YFP
+ neurons varies
between mice. For quantitation (see Results and Figure S2, Panel D), we normalized our data relative to YFP expression in each mouse. For Tat and
control groups, n=3 independent replicates.
doi:10.1371/journal.pone.0023915.g007
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induced neuronal damage and neuroinflammation, it is quite
possible that their ability to strip synapses may become amplified
to a pathologic level - with the result that microglia may elicit
enduring neurotoxic responses [57]. Our morphometric data
(Figure S2, Panel D) demonstrate a 41% increase in leukocyte and
microglial contact with neuronal structures, and when considered
in the context of synaptic elements present as inclusions in
Figure 8. Stereotactic injection of saline control does not
induce engulfment of dendrites. Montage of 3D reconstruction
micrographs of a representative tissue section from right hippocampus
of YFPH mice that received saline control vehicle and were sacrificed
24 hours later (n=3 replicates). Panels A–C depict a 3D reconstruction
of CD11b
+ microglia (red) interacting with YFP
+ pyramidal neurons
(yellow), while Panels D–F show XYZ views at different depths in the
same image stack. Blue arrowheads point to cell-to-cell contact
between microglia and neuronal processes. These points of contact
are illustrated in the XYZ view in Panels D and F (crossing point of the
two blue cursor lines). Panel E shows an XYZ view of a neuronal soma
contacting a microglial process (crossing point of the two blue cursor
lines). Each side of the individual grid=14 mm in Panels A, B, and C, and
the scale bar in Panel D=16 mm for Panels D–F.
doi:10.1371/journal.pone.0023915.g008
Figure 9. Stereotactic injection of Tat induces infiltrating
leukocyte engulfment of dendrites. This is a montage of 3D
reconstruction micrographs of a representative tissue section of right
hippocampus of YFPH mice that received Tat and were sacrificed
24 hours later (n=3 independent replicates). As in Figure 7, Panels A–C
depict a 3D reconstruction of CD11b
+ microglia (red) and infiltrating
leukocytes (also red) interacting with YFP
+ pyramidal neurons (yellow)
while Panels D–F show XYZ views at different depths in the same image
stack. Green arrowhead points to an infiltrating leukocyte phagocytos-
ing a dendritic process from an YFP
+ pyramidal neuron, which is
depicted in the XYZ view in Panel D (crossing point of the two green
cursor lines). In contrast, blue arrowheads identify where microglia
processes appear to ensheath neuronal processes. Panels E and F depict
the XYZ view of this microglial ensheathment of a neuronal process
(crossing point of the two blue cursor lines). Each side of individual
grid=9 mm in Panels A–C, and scale bar in Panel D=10 mm for Panels
D–F.
doi:10.1371/journal.pone.0023915.g009
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at 28 d (Figure 1, Panel D; Figure S1, Panels B, D), this seems like
a reasonable supposition to be investigated in future studies.
In addition to demonstrating the rapid infiltration of inflam-
matory leukocytes into the brain following intracerebral delivery of
HIV-1 Tat, our data suggest that the gene dose of CX3CR1 exerts
a profound regulatory effect on infiltration of inflammatory
leukocytes. Indeed, mice engrafted with homozygous marrow
(CX3CR1-GFP
+/+) had significantly increased numbers of
infiltrating mononuclear cells in response to both saline and Tat
Figure 10. Tat alters ultrastructural relationships between polymorphonuclear granulocytes, microglia and neuronal elements
including synapses in the cerebral cortex of CX3CR1
+/2 mice. This is a montage of electron micrographs 24 hrs (Panels A–D) or 7 d (Panels E,
F) after Tat injection (n=3 independent replicates). Panels A and B show a polymorphonuclear granulocyte (pmn) cell body in apposition to a
microglial process. Panel B presents a higher resolution view of the boxed region in Panel A Two processes arising from the degenerating
polymorphonuclear granulocyte (arrows) surround an Iba-1 immunopositive microglial process (m+) with a cellular inclusion (in). Panel C presents
another example of microglial process with a cellular inclusion. In both Panels B and C, the cellular inclusion appears as engulfed material from
degenerating neurons. In Panel D, a microglial process contains three cellular inclusions resembling profiles of dendrites (‘‘d’’). Direct contacts with
other synaptic elements including dendritic spines (s) and axon terminals (t) are also observed. Panel E shows a microglial process displaying a cellular
inclusion resembling an axon terminal (‘‘t’’; arrows), as well as cellular inclusions resembling a dendrite, suggesting their phagocytic engulfment by
microglia after HIV infection. Panel F presents a higher resolution view of the boxed region in Panel E. a, astrocytic process; d, dendrite; ma,
myelinated axon; n, nucleus; N, neuron; *, extracellular space; scale bars, 1 mm (Panel A) and 0.5 mm (Panels C–E).
doi:10.1371/journal.pone.0023915.g010
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engrafted with heterozygous marrow (CX3CR1-GFP
+/2). This
effect was especially striking in mice that received saline alone. In
contrast, head shielding had no effect on the magnitude of Tat-
mediated leukocyte infiltration into the CNS (Figure S1, Panel B)
[37–39].
Data in this study as well as a previous study [10] demonstrate
that a single injection of Tat into the CNS induces persistent
changes in normal neuronal and microglial cellular architecture.
While in vivo exposure to Tat alone as an experimental model for
HIV-1 neuropathogenesis clearly has its limitations, other murine
models of HIV-1 infection of the CNS [22,23,58] are not
compatible with the adoptive transfer methodologies required to
dissect the relative contribution of peripheral leukocytes vs.
microglia in HIV-1 induced neuroinflammation. Moreover, the
profound and durable CNS changes following a single injection of
Tat are striking, and speak to the ability of this simple, reductionist
model to recapitulate some of the striking features of HAND –
including the puzzling persistence of CNS damage in the absence
of detectable virus loads.
Here we show that, following a single injection of Tat into the
CNS, phagocytic elimination of synaptic structures by microglia
persisted for up to 7 days (Fig. 10) and microgliosis persisted for at
least 28 days (Figs. 1D and S1), while infiltration of peripheral
inflammatory leukocytes was far more ephemeral. Although
ephemeral, this transient leukocyte infiltration may be devastating
to normal neuronal function. Data from experimental models of
stroke and intracerebral hemorrhage suggest that the magnitude of
neutrophil and activated monocyte/macrophage infiltration, as
well as release of soluble inflammatory mediators are associated
with greater neurologic dysfunction [59–61].
In conclusion, our data make a compelling case for a sequence
of events that are initiated by infiltration of mononuclear and
granulocyte subsets of leukocytes in response to the presence of
Tat in the CNS. This is associated with the subsequent engulfment
of microglial processes and dendritic spines by infiltrating
leukocytes and by a microglial response that includes an apparent
‘‘attack’’ on the invading leukocytes. This suggests that peripheral
leukocytes and microglia may make quite different contributions to
the pathogenesis of brain injury associated with HIV-1 infection of
the CNS. The role of microglia in disease may also change over
time, since intercellular communication between invading leuko-
cytes and neurons may trigger the release of ‘find me’ signaling
molecules such as ATP or UTP [62,63]. These signals have the
potential to trigger a switch to an inflammatory phenotype for
microglia – leading to enduring microgliosis and neuroinflamma-
tion, long after the initial viral insult has been cleared. Studies in
progress are focused on the critical signaling cascades that may be
involved in the biphasic microglial response to HIV-induced
neuroinflammation.
Materials and Methods
Reagents
Samples of Tat1–72 were generous gifts from the laboratories of
Avi Nath (John Hopkins University). Antibodies for immunocy-
tochemistry were mouse anti-MAP2 (sigma) 1/2000, mouse anti-
PSD95 (ABR) 1/500, mouse anti-GFAP (clone GA5, Cell
Signaling) 1/1000, mouse anti-MPO (Abcam a16886-50) 1/200,
biotinylated mouse anti-GFP (Rockland) 1/5000, rat anti-mouse
CD11b (clone 5C6 Serotec) 1/400, rat anti-mouse 1-A/1-E
(MHCII) (BD Pharmingen) 1/2000, rabbit anti-GFP (invitrogen
A11122) 1/5000 and Alexa 488 conjugated 1/1000, rabbit anti-
Iba1 (Wako) 1/1000, and rabbit anti-GFAP (Dako) 1/1000. All
the goat secondary antibodies were Alexa dye conjugated highly
cross species absorbed (Invitrogen) 1/500. The following antibod-
ies were purchased from BD Bioscience and used for flow
cytometry analysis of bone marrow chimeras, CD11b-PE (1:1000),
CD45.2-APC (1:250), CD8a-PE (1:1000), B220-PerCP (1:1000),
CD4-PerCP (1:1000), NK1.1-PE (1:1000). All other chemicals and
reagents were purchased from Sigma (St. Louis, MO).
Generation of bone marrow chimeras
Bone marrow cells (10610
6) from CX3CR1-GFP
+/2 or
2/2
mice were injected into the tail veins of lethally irradiated (1000
rad) CD45.1 congenic hosts (or vice-versa). In all cases, the
reconstitution efficiency of CD11b
+ cells exceeded 95% as assessed
by flow cytometry at 4 weeks after irradiation by the method of
Despande [64]. Subsequent to the original experiments using
irradiation chimeras without a head-shield, additional experiments
were performed using a modification of this method, because of
potential concerns that irradiation of the head might lead to
damage to the blood-brain barrier (BBB) [37–39]. Specifically,
CD45.1 host mice were engrafted with heterozygous CX3CR1/
GFP
+/2 bone marrow after receiving 9gv gamma ray irradiation
to the whole body with head shielding from the cesium source,
which yielded similar data described in the Results section.
Stereotactic injection Tat into hippocampus, including
Ethics Statement
12–14 week-old bone marrow chimeric (4 weeks after
engraftment; received bone marrow graft at 8–10 weeks of age)
or wild-type C57Bl/6J mice were used in accordance with the
NIH guidelines for the responsible use and care of animals under
the auspices of the University Committee on Animal Resources
(UCAR) at URMC which fully approved this study (PHS
Assurance: A-3292-01, Protocol Number: 2008-004). Briefly, mice
were anesthetized by i.p. injection of a mixture of ketamine
(120 mg/kg) and xylazine (60 mg/kg), and the head firmly secured
in a stereotaxic frame, 15 mg Tat1–72 in 5 ml PBS or 5 ml PBS was
injected into hippocampus of the right hemisphere using
stereotaxic coordinates of 21.9 mm posterior to the Bregma (see
http://www.mbl.org/atlas170/atlas170_frame.html), 2.3 mm lat-
eral to the midline, and 1.7 mm ventral to the pial surface. A
micro-syringe pump (micro4, WPI, Saratoga, FL) and 10 ml
Hamilton syringe (33 gauge needle coated inside with Sigmacot,
Sigma, St. Louis, MO) were used to deliver 5 ml solution in
10 minutes, followed by an additional 10 minute period prior to
needle withdrawal. Mice were sacrificed at 1 d after Tat1–72 or
control vehicle stereotactic injections for ICC. We also did the Tat
treatment in hippocampus of Thy-1 YFP (Jackson Lab),
CX3CR1/GFP and C57Bl/6 mice and sacrificed at 8 hrs, 1 d,
2 d, 7 d, and 28 d after Tat1–72 or control vehicle injections.
Transcardial perfusion of a periodate-lysine-paraformaldehyde
fixative (PLP, 3.5% paraformaldehyde) [65] was used to fix the
brain tissue.
Immunocytochemistry
40 mm sections were cut from fixed brains using a vibratome
(Leica VT1000S). Immunocytochemical staining with a combina-
tion of up to 4 different antibodies, including CD11b, IBA1,
GFAP, MHCII, MPO, Tuj1, MAP2, and GFP in conjunction
with various fluorescent (Alexa 350, 405, 488, 555, 647 or 660 dye
[1:500], Invitrogen) secondary antibodies were incubated using a
free floating tissue sections. All primary antibody concentrations
were optimized in our laboratory based on pilot experiments with
multiple antibody combinations. Sections were mounted on glass
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without or with DAPI (Invitrogen), depending on whether an
Alexa 350 or 405 secondary antibodies were used to detect the
primary antibody.
Stereotactic injection Tat into cortex and
Immunocytochemical EM
12 to14 week-old CX3CR1
+/2 mice received cortical injections
of either 9 mg Tat1–72 in 3 ml PBS or 3 ml PBS (vehicle control)
using a 35 gauge needle with the same microsyringe pump
delivering system as described above but at a rate of 80 nl/min.
Reagents were delivered to the stereotactic coordinates: 21.0. mm
posterior to bregma (see http://www.mbl.org/atlas170/atlas170_-
frame.html), 1.5 mm lateral to the midline, and 0.8 mm ventral to
the pial surface. At sacrifice, mice used for EM analyses were
anesthetized with sodium pentobarbital (80 mg/kg, i.p.) and
perfused through the aortic arch with 3.5% acrolein followed by
4% paraformaldehyde [66]; groups of animals (n=3 each) were
sacrificed at both 24 hrs and 7 d after Tat or PBS (control)
injections. Transverse sections of the brain (50 mm thick) were cut
in ice-cooled PBS (0.9% NaCl in 50 mM phosphate buffer,
pH 7.4) with a vibratome, immersed in 0.1% sodium borohydride
for 30 min at room temperature (RT), washed in PBS, and
processed freely floating following a pre-embedding immunoper-
oxidase protocol previously described [66]. Briefly, sections were
rinsed in PBS, pre-incubated for 2 hrs at RT in a blocking solution
of PBS containing 5% normal goat serum and 0.5% gelatin,
incubated for 48 hrs at RT in rabbit anti-Iba1 antibody (1:1,000 in
blocking solution; Wako Pure Chemical Industries), and rinsed in
PBS. After incubation for 2 hrs at RT in goat anti-rabbit IgGs
conjugated to biotin (Jackson Immunoresearch) and with strepta-
vidin-horseradish peroxidase (Jackson Immunoresearch) for 1 hr
at RT in blocking solution, labeling was revealed with diamino-
benzidine (0.05 mg/ml) and hydrogen peroxide (0.03%) in buffer
solution (DAB Peroxidase Substrate Kit; Vector Laboratories).
Sections were afterwards post-fixed flat in 1% osmium tetroxide,
dehydrated in ascending concentrations of ethanol, treated with
propylene oxide, impregnated in Durcupan (Electron Microscopy
Sciences) overnight at RT, mounted between ACLAR embedding
films (Electron Microscopy Sciences), and cured at 55uC for
48 hrs. Areas located between 2 and 3 mm from the injection site
were excised from the embedding films and re-embedded at the tip
of resin blocks. Ultrathin (65–80 nm) sections were cut with an
ultramicrotome (Reichert Ultracut E), collected on bare square-
mesh grids, stained with lead citrate, and examined with a Hitachi
7650 electron microscope.
In each animal, a total surface of >1,000 mm
2 of neuropil was
examined. Microglia, neurons, and degenerating neurons were
identified according to criteria previously defined [56,67–71].
Degenerating neurons displayed a dark nucleus and cytoplasm,
ruffling of the plasma membrane, and extensive invagination of
the nuclear membrane, similarly to degenerating neurons in
Alzheimer and Huntington disease mouse models and human
postmortem brains [67,70,71]. In addition to their immunoreac-
tivity for IBA1, microglia were distinguished by their distinctive
long stretches of endoplasmic reticulm, frequent vacuoles and
cellular inclusions, irregular contours with obtuse angles, and
associated extracellular space.
Image analyses
Multi-channel Z-stacks of fluorescence images were taken with a
epifluorescence microscope equipped with Opti-Grid structured
light illumination that effectively subtracts the out-of-focus
fluorescence to achieve a confocal-like image sequence for 3D
reconstruction of the spatial relationships among different cell
types labeled by antibody immunostaining in the hippocampus.
Volocity 3DM (Improvision, Perkin Elmer, Waltham, MA)
software suites were used on a Mac G5 computer for image
acquisition and analyses. For morphometric quantification of
either GFP
+ or MPO
+ cell types or cell-to-cell contacts, statistical
analyses of data were performed with SPSS software (IBM; http://
www.spss.com), and the particular tests used to ascertain
significance at the p#0.05 level are reported in the Results
section. To qualitatively assess polymorphonuclear cells (PMNs)
infiltration into the CNS, we mounted 1/8 of sections on gelatin-
coated slides, stained with H&E, followed by dehydration and
coverslipping with permount. A neuropathologist (M.J.), blinded to
treatment conditions, then analyzed 4 sections/mouse, from
groups of Tat or vehicle treated animals (n=3 each) for the
presence of PMNs present in hippocampus.
Supporting Information
Figure S1 Stereotactic injection of Tat induces differ-
ential antigen expression in microglia. This is a montage of
hippocampal fields at the injection site 28 d after exposure to
vehicle (Panels A, C) or Tat (Panels B, D). Panels A and B depict
Iba-1 immunostaining of microglia, while Panels C and D depict
the same fields with CD11b immunostaining of these microglia.
For Tat and control conditions, n=3 independent replicates.
Scale bar=20 mm.
(TIF)
Figure S2 Head-shielding during cranial irradiation
does not significantly alter cell counts of Tat-mediated
infiltration of leukocytes. (Panel A); effects of CX3CR1 gene
dose on Tat-mediated infiltration of leukocytes (Panel B); effects of
Tat on granulocyte infiltration (Panel C) and effects of Tat on
volume changes of leukocyte and microglial contacts with neurons
(Panel D): In Panels A–D, mice received Tat or vehicle control
into hippocampus as described below and were sacrificed 24 hr
later. GFP+ or MPO+ cells were counted from 3 sections from
each of 3 mice that received Tat or vehicle. The injection site was
located in the lateral part of the hippocampus for all the mice
treated with Tat or control vehicle, and we counted the total
number of GFP+ or MPO+ cells from the whole field of each of
three consecutive sections of medial hippocampus separated by
320 mm that were captured using a 106 objective. Total cell
counts 6 SD for each type of GFP- or MPO-labeled leukocytes for
Tat or vehicle control are from 3 independent replicates. For
panels A–C, significance was determined by one-way ANOVA
with Tukey’s HSD posthoc test. For Panel D, we measured the
amount of contact between CD11b
+ structures, i.e. labeled
leukocytes and microglia, and YFP
+ neuronal structures as the
intersecting volume between the two from 3D image sets at least
500 mm away from the stereotactic injection site from 4 Tat
treated and 3 vehicle treated mice using Volocity 3DM software.
Because of the variability of hippocampal YFP expression between
mice, we normalized the intersecting volume between CD11b
+
and YFP
+ structures by dividing it with the product of total
CD11b
+ volume and total YFP
+ volume from each individual
image set. Here significance was determined by paired T-tests.
*
,#=P,0.001.
(TIF)
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